Erin Quirk - 28 Sep 2021 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
President and CMO
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Erin Quirk
Issuer symbol
TERN
Transactions as of
28 Sep 2021
Transactions value $
$0
Form type
4
Filing time
30 Sep 2021, 21:14:45 UTC
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +143K $0.00 143K 28 Sep 2021 Common Stock 143K $10.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from September 28, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.